CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-02 | Murthy Mala Chief Financial Officer | Option exercise | +4,552 | 16,314 | ||
| 2021-03-02 | Murthy Mala Chief Financial Officer | Option exercise · Restricted Stock Units | −2,678 | 5,355 | ||
| 2021-03-02 | Murthy Mala Chief Financial Officer | Grant or award · Performance Stock Units | +13,656 | 13,656 | ||
| 2021-03-02 | Murthy Mala Chief Financial Officer | Option exercise · Performance Stock Units | −4,552 | 9,104 | ||
| 2021-03-02 | Murthy Mala Chief Financial Officer | Grant or award · Restricted Stock Units | +7,457 | 7,457 | ||
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Sale | −12,674 | $224.28 | $2.8M | 541,739 |
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Option exercise | +9,104 | 550,843 | ||
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Option exercise | +15,476 | 566,319 | ||
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Sale | −30,000 | $223.53 | $6.7M | 536,319 |
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Option exercise · Restricted Stock Units | −9,104 | 18,207 | ||
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Grant or award · Performance Stock Units | +46,430 | 46,430 | ||
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Option exercise · Performance Stock Units | −15,476 | 30,954 | ||
| 2021-03-02 | GOREVIC JASON N Chief Executive Officer | Grant or award · Restricted Stock Units | +22,944 | 22,944 | ||
| 2021-03-01 | Verstraete Stephany Chief Marketing Officer | Option exercise | +3,169 | 16,445 | ||
| 2021-03-01 | Verstraete Stephany Chief Marketing Officer | Option exercise | +6,031 | $22.30 | $134K | 22,476 |
| 2021-03-01 | Verstraete Stephany Chief Marketing Officer | Option exercise | +969 | $38.55 | $37K | 23,445 |
| 2021-03-01 | Verstraete Stephany Chief Marketing Officer | Sale | −7,000 | $227.00 | $1.6M | 16,445 |
| 2021-03-01 | Verstraete Stephany Chief Marketing Officer | Option exercise · Restricted Stock Units | −3,169 | 0 | ||
| 2021-03-01 | Verstraete Stephany Chief Marketing Officer | Option exercise · Employee Stock Option (right to buy) | −6,031 | 6,569 | ||
| 2021-03-01 | Verstraete Stephany Chief Marketing Officer | Option exercise · Employee Stock Option (right to buy) | −969 | 46,331 |
Page 80 of 93 · 1,848 trades